Microbes. Mind. Medicine.™

NATURAL. LIVE. TRANSFORMATIVE.

New hope for mental health starts in the microbiome.

We are developing natural, live bacterial therapies aimed at improving the lives of people with Bipolar Disorder, OCD, and General Depressive Disorder.

Be the first to know.

Sign up to receive updates on our research, clinical progress, and product availability.

🔒 We respect your privacy. Unsubscribe anytime.

Targeting the root cause. Restoring balance.

Our novel psychobiotic therapies are designed to modulate the gut–brain axis and support mental well-being at its source.

Natural & Live

Using beneficial live bacteria strains to influence the microbiome and support brain health.

Evidence-Driven

Built on cutting-edge research and a deep understanding of the gut–brain connection.

Life-Changing Potential

Focused on Bipolar Disorder, OCD, and General Depressive Disorder — conditions that deserve better options.

We’re just getting started.

Join us on this journey to transform mental health through the power of nature and science.

Asem Bala

MSc

Asem Bala, MSc has over 20 years of experience in Healthcare & Clinical Research Management, now working at Taylored Biotherapeutics to create partnerships and ensure regulatory approvals.

Dr. Valerie Taylor

MD, PhD, FRCP

Dr. Valerie Taylor, MD, PhD, FRCP is a Professor of Psychiatry at the University of Calgary. She completed a Bachelor of Medical Science and graduated from medical school at Memorial University of Newfoundland. She subsequently finished her residency training in Psychiatry and got her PhD in Neuroscience from McMaster University in Hamilton, Ontario. Prior to coming to Calgary, she was the chief of Psychiatry at the Women’s College Hospital and the chief of Adult Health Services at the Center for Addiction and Mental Health in Toronto.

Her academic focus has been on the area of medical psychiatry – specifically, for the last 5 years, on the gut brain axis and the the gut microbiome. She is the only funded researcher in North America examining the therapeutic effects of fecal transplant as a treatment for mental health and she currently has 4 novel clinical trials looking at modifying the gut microbiome to treat mood disorders as well as the largest biological neuroscience microbiome repository in North America. She has over 180 peer reviewed publications and funding from a variety of national and international funding agencies. In 2020 she started Taylored Biotherapeutics, a micro therapeutics drug company. Today her primary role is in leading product development, getting regulatory approval, and finding partnerships.

Receive the latest news

Join Our Journey

Be the First to Know: Unlock exclusive updates on the progress and launch timeline of our groundbreaking biotherapeutics product development.

Name(Required)